BioMarin Pharmaceutical
BMRN
#1489
Rank
NZ$18.87 B
Marketcap
$98.42
Share price
0.60%
Change (1 day)
-35.25%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): NZ$0.90 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are NZ$2.85 Billion. , an increase over its 2023 earnings that were of NZ$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.90 B187.31%
2023 NZ$0.31 B26.07%
2022 NZ$0.24 B-298.51%
2021 -NZ$0.13 Billion78.04%
2020 -NZ$70.4 Million-55.36%
2019 -NZ$0.16 Billion-33.56%
2018 -NZ$0.24 Billion297.78%
2017 -NZ$59.68 Million-95.68%
2016 -NZ$1.39 Billion437.12%
2015 -NZ$0.26 Billion23.91%
2014 -NZ$0.21 Billion-29.25%
2013 -NZ$0.3 Billion49.23%
2012 -NZ$0.2 Billion171.11%
2011 -NZ$72.57 Million103.01%
2010 -NZ$35.75 Million-3903.54%
2009 NZ$0.93 M-98.31%
2008 NZ$55.59 M-189.7%
2007 -NZ$61.98 Million51.02%
2006 -NZ$41.05 Million-61.58%
2005 -NZ$0.11 Billion-56.59%
2004 -NZ$0.25 Billion95.13%
2003 -NZ$0.13 Billion12.09%
2002 -NZ$0.12 Billion73.19%
2001 -NZ$64.95 Million18.32%
2000 -NZ$54.9 Million19.65%
1999 -NZ$45.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.84 Billion-193.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.17 Billion-118.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.48 M-98.61%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.20 B 1,365.96%๐Ÿ‡ซ๐Ÿ‡ท France
-NZ$47.83 Million-105.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.35 B-60.08%๐Ÿ‡บ๐Ÿ‡ธ USA